Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL
Sulfacetamide Sodium and Prednisolone Sodium Phosphate · SOLUTION/ DROPS · NuCare Pharmaceuticals,Inc.
This eye drop medication combines an antibiotic (sulfacetamide sodium) and a corticosteroid (prednisolone sodium phosphate) to treat bacterial eye infections and reduce inflammation. It is applied directly to the eye as prescribed by your doctor.
Key Facts
- Brand Name
- Sulfacetamide Sodium and Prednisolone Sodium Phosphate
- Generic Name
- Sulfacetamide Sodium and Prednisolone Sodium Phosphate
- NDC Code (Product)
68071-1650- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Strength
- 2.3 mg/mL
- Dosage Form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- ANDA074449
- Marketing Start
- 12/29/1995
Recall History
No Recall HistoryFrequently Asked Questions
What is Sulfacetamide Sodium and Prednisolone Sodium Phosphate used for?
This eye drop medication combines an antibiotic (sulfacetamide sodium) and a corticosteroid (prednisolone sodium phosphate) to treat bacterial eye infections and reduce inflammation. It is applied directly to the eye as prescribed by your doctor.
Is Sulfacetamide Sodium and Prednisolone Sodium Phosphate a controlled substance?
Sulfacetamide Sodium and Prednisolone Sodium Phosphate is not classified as a controlled substance by the DEA.
What is the generic name for Sulfacetamide Sodium and Prednisolone Sodium Phosphate?
The generic name for Sulfacetamide Sodium and Prednisolone Sodium Phosphate is Sulfacetamide Sodium and Prednisolone Sodium Phosphate. There are no other listed brand versions of Sulfacetamide Sodium and Prednisolone Sodium Phosphate.
What is the NDC code for Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL?
The NDC (National Drug Code) for Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL is 68071-1650, listed by NuCare Pharmaceuticals,Inc..
Other Sulfacetamide Sodium and Prednisolone Sodium Phosphate Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)